Organisation paid for research Program year 2025 Source: CMS Open Payments

Wa Univ

Neither a doctor nor a teaching hospital

Research payments

$1,479,971

111 payments

Through program year 2025, Wa Univ is reported as receiving $1,479,971 in research payments, across 111 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$599,516	26
2024	Research	$674,763	38
2023	Research	$43,739	9
2022	Research	$80,051	6
2020	Research	$41,056	7
2019	Research	$40,846	25

Breakdown

Who paid Research payments · program years 2019–2025

Janssen Research & Development, LLC $1,425,535 91 payments
Actelion Pharmaceuticals, Ltd $41,056 7 payments
Medical Device Business Services, Inc. $13,380 13 payments

Studies the money was for Research payments · program years 2019–2025

Arx517-2011 $538,773 12 payments
A Phase 1, Multicenter, Open-Label, Dose-Escalation, and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of ARX517 as Monotherapy and in Combination With Androgen Receptor Pathway Inhibitors in Subjects With Metastatic Prostate Cancer $454,806 18 payments
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd $143,540 6 payments
Phase 3 Multi Center Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy Safety Pharmacokinetics and Pharmacodynamics of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis $78,451 4 payments
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension $41,056 7 payments
78934804Uco2001 $34,306 5 payments
78934804Crd2001 $34,110 5 payments
68284528Mmy4002 $32,677 8 payments
54767414Mmy3030 $27,442 7 payments
17000139Blc2002 $25,270 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.